NORTH CHICAGO, Ill. - The U.S. Food and Drug Administration (FDA) has approved EMBLAVEO™ (aztreonam and avibactam) for the ...

AbbVie received Food and Drug Administration approval of Emblaveo, an intravenous antibiotic, for treatment of adults with complicated intra-abdominal infections with limited or no treatment options.

AbbVie said on Friday that the U.S. Food and Drug Administration approved its drug for complicated intra-abdominal infections ...

AbbVie (ABBV) announced that the U.S. Food and Drug Administration has approved EMBLAVEO, as the first and only fixed-dose, intravenous, ...

The drug manufacturers and hospitals say that the cost of medicine will rise due to the tariff and there could be an impact ...

In 2017, a tragic incident unfolded in a Nevada hospital. A woman, admitted for pneumonia, tragically succumbed to multiple ...

Overall, 45.8% of COVID-19 hospital admissions and 51.2% of admissions for other respiratory viruses received at least one ...

Scientists are learning more about how an intriguing type of virus protects itself. Revealing its strategies could boost the fight against antibiotic resistance.

The data suggests that the body's use of nutrient scarcity as a defense mechanism may actually enable bacteria's survival in the long run.

Microbes that reside peaceably in the nasal passageways and on the skin can be harnessed for taking drugs to target cells.

Scientists are learning more about how an intriguing type of virus protects itself. Revealing its strategies could boost the fight against antibiotic ...

Herbs and supplements were the most common treatment offered by the clinics (53 clinics; 45%) followed by non-antibiotic intravenous therapy (26%), unspecified antibiotics (22%), hyperbaric oxygen ...